Working… Menu

Observational Study of Rapid Sequence Intubation (RSI) Drug Delivery Using Intraosseous (IO) and Intravenous (IV) Access.

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01486407
Recruitment Status : Terminated (For poor enrollment)
First Posted : December 6, 2011
Last Update Posted : February 1, 2013
Information provided by (Responsible Party):
Vidacare Corporation

Brief Summary:
This study will evaluate using intraosseous vascular access and intravenous vascular access to give patients the necessary medications to perform rapid sequence intubation, for patients with airway difficulties. The investigators think the device operator will find the intraosseous and intravenous routes equal for drug delivery.

Condition or disease
Airway Control

Detailed Description:
This observational study will evaluate the intubating conditions of patients receiving rapid sequence intubation when receiving paralytic drug delivery via intravenous or intraosseous vascular access from the perspective of the medical professional performing rapid sequence intubation. The investigators believe that medical professionals will find equal intubating conditions for intravenous and intraosseous drug delivery.

Layout table for study information
Study Type : Observational
Actual Enrollment : 2 participants
Observational Model: Case-Control
Time Perspective: Prospective
Official Title: An Observational Study of Intubating Conditions Comparing Intraosseous Vascular Access With Peripheral Intravenous Access for Drug Delivery in Rapid Sequence Intubation
Study Start Date : February 2012
Actual Primary Completion Date : December 2012
Actual Study Completion Date : December 2012

Intravenous (IV) drug delivery
patients on whom intravenous vascular access has been established for the purpose of rapid sequence intubation drug delivery.
Intraosseous (IO) drug delivery
Patients on whom intraosseous vascular access has been established for rapid sequence intubation drug delivery.

Primary Outcome Measures :
  1. Time from first drug delivery to operator-perceived sufficient relaxation to perform endotracheal tube placement [ Time Frame: during rapid sequence intubation procedure, average expected time frame 30 minutes ]
  2. Intubation difficulty using the intubation difficulty scale [ Time Frame: during rapid sequence intubation procedure, average expected time frame 30 minutes ]
  3. Operator satisfaction with intubating conditions using visual analog scale [ Time Frame: during rapid sequence intubation procedure, average expected time frame 30 minutes ]
  4. Failure rate of endotracheal intubation and requirement for alternative airway management methods [ Time Frame: during rapid sequence intubation procedure, average time frame 30 minutes ]

Secondary Outcome Measures :
  1. Incidence of short-term catheter related complications for each technique [ Time Frame: during emergency department stay, average time frame 24 hours ]

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.

Layout table for eligibility information
Ages Eligible for Study:   Child, Adult, Older Adult
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
Patients in the emergency department with airway difficulties requiring rapid sequence intubation.

Inclusion Criteria:

  • Requires rapid sequence intubation
  • Succinylcholine is chosen paralytic agent
  • IV or IO access has been established for rapid sequence intubation
  • For IV access patients, their rapid sequence intubation case is the next occurring IV rapid sequence intubation case following an enrolled IO RSI case.

Exclusion Criteria:

  • Vascular access other than IV or IO has been established

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its identifier (NCT number): NCT01486407

Layout table for location information
United States, Texas
Christus Spohn Hospital Corpus Christi
Corpus Christi, Texas, United States, 78405
Texas Tech University Health Science Center El Paso
El Paso, Texas, United States, 79905
Sponsors and Collaborators
Vidacare Corporation
Layout table for investigator information
Principal Investigator: Stephen W Borron, MD Texas Tech University Health Science Center
Brierley J, Carcillo JA, Choong K, Cornell T, Decaen A, Deymann A, Doctor A, Davis A, Duff J, Dugas MA, Duncan A, Evans B, Feldman J, Felmet K, Fisher G, Frankel L, Jeffries H, Greenwald B, Gutierrez J, Hall M, Han YY, Hanson J, Hazelzet J, Hernan L, Kiff J, Kissoon N, Kon A, Irazuzta J, Lin J, Lorts A, Mariscalco M, Mehta R, Nadel S, Nguyen T, Nicholson C, Peters M, Okhuysen-Cawley R, Poulton T, Relves M, Rodriguez A, Rozenfeld R, Schnitzler E, Shanley T, Kache S, Skippen P, Torres A, von Dessauer B, Weingarten J, Yeh T, Zaritsky A, Stojadinovic B, Zimmerman J, Zuckerberg A. Clinical practice parameters for hemodynamic support of pediatric and neonatal septic shock: 2007 update from the American College of Critical Care Medicine. Crit Care Med. 2009 Feb;37(2):666-88. doi: 10.1097/CCM.0b013e31819323c6. Erratum in: Crit Care Med. 2009 Apr;37(4):1536. Skache, Sara [corrected to Kache, Saraswati]; Irazusta, Jose [corrected to Irazuzta, Jose].

Layout table for additonal information
Responsible Party: Vidacare Corporation Identifier: NCT01486407    
Other Study ID Numbers: 2011-13
First Posted: December 6, 2011    Key Record Dates
Last Update Posted: February 1, 2013
Last Verified: January 2013
Keywords provided by Vidacare Corporation:
Airway management